British American Tobacco/£BATS

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About British American Tobacco

The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.

Ticker

£BATS

Primary listing

LSE

Employees

48,989

BATS Metrics

BasicAdvanced
£84B
27.80
£1.38
0.16
£2.38
6.28%

What the Analysts think about BATS

Analyst ratings (Buy, Hold, Sell) for British American Tobacco stock.

Bulls say / Bears say

British American Tobacco exceeded first-half 2025 profit estimates, driven by a 3.7% constant-currency revenue increase in its largest U.S. market and a 3.9% rise in “new category” products, with smokeless segments now over 18% of total revenue (Reuters)
After selling a 2.3% stake in India’s ITC, BAT increased its 2025 share buyback programme by £200 million to £1.1 billion, underlining its commitment to enhanced shareholder returns (Reuters)
BAT raised its full-year sales growth target to 1%–2%, citing stronger-than-expected first-half revenue and forecasting mid-single-digit growth in next-generation products despite market headwinds (Reuters)
BAT faces ongoing financial pressure from a proposed C$32.5 billion settlement in a Canadian class-action lawsuit, equivalent to approximately £6.2 billion, which could dent future earnings and cash flows (Reuters)
The company’s “new categories” segment faces fierce competition from illicit flavoured disposable vapes in the U.S. and Canada, potentially limiting growth in its core next-generation products (Reuters)
The imposition of new 19% tariffs on Vuse devices produced in Indonesia risks margin compression in the U.S. vape market if additional costs cannot be fully absorbed as planned (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2025.

BATS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BATS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £BATS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs